Febuxostat effectively reduces uric acid but has a limited renoprotective effect on renal transplant recipients with hyperuricemia: a meta-analysis.

Front Pharmacol · 2026 · PMC12993176 · PMID 41853491

Europe PMC DOI

hedged sentence

0.3370

closest p · 6.7× alpha

0.3370

boldest claim

The sentences

did not reach statistical significanceP = 0.337not close (p > 0.1)

Febuxostat numerically reduced the Cr level but did not reach statistical significance, with an MD of 2.390 μmol/L ( P = 0.337, Figure 3A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.